top of page
![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Boston_H_color%5B33632%5D_edited.png)
Wed, Sep 12
|Fleming’s Prime Steakhouse & Wine Bar
CANCELLED - Immunotherapy for Patients with NSCLC Following Chemoradiation
Indication: IMFINZI is indicated for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
Registration is Closed as this event has been Cancelled
See other events
Time & Location
Sep 12, 2018, 6:15 PM
Fleming’s Prime Steakhouse & Wine Bar, 217 Stuart St, Boston, MA 02116, USA
Guests
About The Event
We regret to inform you this event has been cancelled.
To find out more information or to register for this meeting, please contact Susan Predaris at susan.predaris@astrazeneca.com or (603) 247-1306.
bottom of page